NCT02971176
Low-dose Protocol for Computed Tomography-guided Lung Biopsy No drug interventions diagnostic Not Available completed NCT05228795
Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung No drug interventions Not Available Not Available unknown_status NCT04122833
Impact of Concomitant Genetic Alterations in EGFR Mutated Adenocarcinoma by NGS Analysis: A Multicenter Study No drug interventions Not Available Not Available recruiting NCT02616211
An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors No drug interventions Not Available Not Available completed NCT06215885
Multi-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid Nodules No drug interventions Not Available Not Available not_yet_recruiting NCT03090815
Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma No drug interventions Not Available Not Available unknown_status NCT03059641
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China No drug interventions Not Available Not Available completed NCT02946216
ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC No drug interventions Not Available Not Available unknown_status NCT06299163
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03298763
Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT05079022
ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas treatment 1 / 2 unknown_status NCT05245630
Comparison of Robotic Arm-assisted PET/CT-guided Lung Biopsy With PET Fused CT- Fluoroscopy-guided Lung Biopsy No drug interventions Not Available Not Available completed NCT06441357
Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter No drug interventions Not Available Not Available recruiting NCT02493582
The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR treatment 2 active_not_recruiting NCT05252676
Evaluation of Correlations Between Radiologic Features and Pathologic Subtypes of GGO LUAD Via WMS (ECTOP-1011) No drug interventions Not Available Not Available completed NCT03676192
To Compare Efficacy and Safety of CT-P16 and EU-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer treatment 3 unknown_status NCT05665504
Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer No drug interventions Not Available Not Available recruiting NCT02804646
Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma treatment 4 unknown_status NCT03371381
An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the Lung treatment 1 / 2 terminated NCT05764954
A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma No drug interventions treatment 1 recruiting NCT05565677
Prognostic Value of Lung Cancer MicroAnatomy in 3D No drug interventions Not Available Not Available not_yet_recruiting NCT00073398
Vaccine Treatment for Advanced Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT05550961
APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch No drug interventions Not Available Not Available recruiting NCT03184571
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced NSCLC treatment 2 completed NCT04770688
Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib treatment 1 / 2 completed NCT03838588
The Tracking Molecular Evolution for NSCLC (T-MENC) Study No drug interventions Not Available Not Available unknown_status NCT05456256
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma treatment 2 recruiting NCT04566432
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients No drug interventions Not Available Not Available recruiting NCT05292859
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs No drug interventions Not Available Not Available active_not_recruiting NCT04165759
HRCT in Prediction of Tumor Invasion in GGO Lung Adenocarcinoma (ECTOP-1008) No drug interventions Not Available Not Available completed NCT04105270
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial treatment 2 recruiting NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors treatment 1 / 2 recruiting NCT03361319
Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC Adenocarcinoma treatment 1 / 2 withdrawn NCT04692935
Comparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched Analysis No drug interventions Not Available Not Available unknown_status NCT05194735
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors treatment 1 / 2 active_not_recruiting NCT04086680
The Detection of EGFR Mutations in Liquid Based Cytology Samples No drug interventions Not Available Not Available completed NCT04027946
LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC) treatment 2 terminated NCT05566223
CISH Inactivated TILs in the Treatment of NSCLC treatment 1 / 2 not_yet_recruiting NCT01362790
SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma treatment 1 / 2 completed NCT00369551
Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer treatment 1 terminated NCT01345851
Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery treatment Not Available active_not_recruiting NCT00118183
Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT00020709
Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery treatment 3 completed NCT00511485
Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03) treatment 2 completed NCT01557959
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT02288026
Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT00021060
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer treatment 2 / 3 completed NCT00368992
S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT02059967
Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC treatment 1 withdrawn NCT02466568
Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung treatment 1 / 2 withdrawn NCT02134912
S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib treatment 2 terminated NCT02264210
Icotinib for Completed Resected IB NSCLC With EGFR Mutation treatment 2 recruiting NCT01668823
Photodynamic Therapy in Treating Patients With Lung Cancer treatment 1 completed NCT01707823
Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer basic_science 0 terminated NCT00005838
Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery treatment 3 completed NCT04459078
Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma treatment 2 active_not_recruiting NCT01561456
Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung treatment 2 completed NCT02239432
Telomere Biology in Early Adenocarcinoma of the Lung No drug interventions Not Available Not Available unknown_status NCT00002852
Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer treatment 3 completed NCT01935336
Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers treatment 2 completed NCT01218516
A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung treatment 2 completed NCT01726296
Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care No drug interventions health_services_research Not Available completed NCT00042835
Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer treatment 1 terminated NCT00040794
Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer treatment 2 completed NCT01259089
Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00118144
Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer treatment 2 completed NCT01958372
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer treatment 1 completed NCT00087412
S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer treatment 2 completed NCT03041181
Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor treatment 2 terminated NCT04046614
Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology treatment 1 / 2 completed NCT00049543
Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery treatment 3 completed NCT02715102
Circulating Tumor DNA in Patients at High Risk for Lung Cancer No drug interventions Not Available Not Available terminated NCT02621333
Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma treatment 2 terminated NCT01578551
Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma. treatment 2 terminated NCT01249053
Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma No drug interventions Not Available Not Available unknown_status NCT05838053
Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm No drug interventions Not Available Not Available recruiting NCT04625647
Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) treatment 2 recruiting NCT05794698
Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014) No drug interventions Not Available Not Available completed NCT00955305
Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer treatment 2 terminated NCT05012397
Milademetan in Advanced/Metastatic Solid Tumors treatment 2 terminated NCT06255197
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers No drug interventions Not Available Not Available recruiting NCT05498597
AMT-151 in Patients With Selected Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT04937283
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm No drug interventions treatment Not Available recruiting NCT05794711
Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1015) No drug interventions Not Available Not Available recruiting NCT02843711
Molecular Analysis of 150 Lung Adenocarcinoma No drug interventions Not Available Not Available unknown_status NCT06477211
DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma No drug interventions Not Available Not Available recruiting NCT02691871
Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR treatment 1 unknown_status NCT04432207
A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer treatment 1 active_not_recruiting NCT05191485
Shared Decision Making in Patients With Lung Cancer No drug interventions Not Available Not Available recruiting NCT01386385
Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery treatment 1 / 2 active_not_recruiting NCT02951637
Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial treatment 2 unknown_status NCT04893200
Radiomics-based Prediction Model of Tumor Spread Through Air Space in Lung Adenocarcinoma No drug interventions Not Available Not Available completed NCT04691375
A Study of PY314 in Subjects With Advanced Solid Tumors treatment 1 terminated NCT03704870
Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection No drug interventions other 2 completed NCT04339218
Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma treatment 3 recruiting NCT04929041
Testing the Addition of Radiation Therapy to Immunotherapy for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative treatment 2 / 3 recruiting NCT03905317
Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene treatment 2 unknown_status NCT04119024
Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors treatment 1 recruiting NCT05794724
Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1016) No drug interventions Not Available Not Available recruiting NCT03486496
Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation treatment 2 unknown_status NCT02788058
A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy treatment 2 unknown_status NCT02121925
Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up No drug interventions Not Available Not Available terminated NCT05198830
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer treatment 2 recruiting NCT02898857
Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung Adenocarcinoma No drug interventions Not Available Not Available unknown_status NCT01249066
Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma No drug interventions Not Available Not Available unknown_status NCT05982574
Tumor Microenvironment No drug interventions Not Available Not Available active_not_recruiting NCT02737774
Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation treatment 2 unknown_status NCT05526573
Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions No drug interventions Not Available Not Available recruiting NCT03891173
A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma treatment 2 terminated NCT01942629
Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas No drug interventions Not Available Not Available unknown_status NCT05558904
An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer diagnostic 1 / 2 recruiting NCT05797168
Phase I/IIa Study for AZD5335 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Solid Tumors treatment 1 / 2 recruiting NCT05266846
Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK treatment 2 recruiting NCT06181812
Pathogenic Variants in Genes Associated With Lung Adenocarcinoma No drug interventions Not Available Not Available recruiting NCT00126581
Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer treatment 2 completed NCT05136014
Evaluation of the Response to Tyrosine Kinase Inhibitors in Localized Non-small Cell Lung Cancer (NSCLC) Patients With EGFR Mutation in a Patient-derived Organoid Model No drug interventions Not Available Not Available unknown_status NCT05527808
A Single-arm Exploratory Study of Neoadjuvant Therapy treatment Not Available recruiting NCT02679443
Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy No drug interventions prevention Not Available completed NCT05717803
Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012) No drug interventions treatment 3 recruiting NCT03076164
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib treatment 1 / 2 completed NCT04588064
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma No drug interventions diagnostic Not Available unknown_status NCT01737502
Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer treatment 1 / 2 completed NCT05675033
Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma treatment 2 not_yet_recruiting NCT03199651
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer No drug interventions health_services_research Not Available recruiting NCT04740047
Cios Mobile 3D Spin for Robotic Bronchoscopy No drug interventions Not Available Not Available completed NCT02186847
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT02787447
Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy treatment 2 unknown_status NCT03054298
CAR T Cells in Mesothelin Expressing Cancers No drug interventions treatment 1 completed NCT02011997
Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion No drug interventions treatment 3 unknown_status NCT03922828
Lung Nodule Prospective Database No drug interventions Not Available Not Available completed NCT05395611
Exhaled Breath Particles in Lung Cancer No drug interventions Not Available Not Available recruiting NCT05517811
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection No drug interventions Not Available Not Available recruiting NCT06104709
Local and Peripheral Immune Responsive Landscape Induced by Local Cryoablation in Patients With Lung Adenocarcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT00716456
Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib treatment 1 / 2 completed NCT01482585
Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy No drug interventions Not Available Not Available unknown_status NCT00334815
Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery treatment 2 active_not_recruiting NCT06056115
Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic treatment Not Available recruiting NCT03376737
Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma treatment 2 unknown_status NCT02093000
A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma Not Available Not Available completed NCT02127359
Whole-Exome Sequencing (WES) of Cancer Patients No drug interventions Not Available Not Available completed NCT04554875
Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules No drug interventions Not Available Not Available unknown_status NCT01294306
MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy treatment 2 completed NCT04870034
Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer treatment 0 withdrawn NCT05528458
Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma treatment 2 recruiting NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) No drug interventions Not Available Not Available unknown_status NCT02759835
Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib treatment 2 completed NCT03904563
Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma treatment 2 completed NCT05537922
I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy No drug interventions Not Available Not Available recruiting NCT05010330
Identify Prognostic Biomarkers of Lung Cancer No drug interventions Not Available Not Available unknown_status NCT04861948
IBI188 Combination Therapy in Solid Tumors treatment 1 terminated NCT02399566
Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma treatment 4 unknown_status NCT00950365
Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT04965831
Furmonertinib as Perioperation Therapy in Stage IIIA-IIIB (N1-N2) Resectable EGFR Mutated Lung Adenocarcinoma (FRONT) treatment 2 not_yet_recruiting NCT04682431
A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors treatment 1 terminated NCT04802876
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors treatment 2 recruiting NCT02980991
Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002) treatment 2 completed NCT05736991
Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung Adenocarcinoma No drug interventions Not Available Not Available recruiting NCT04482829
TCM in the Treatment of Lung Adenocarcinoma No drug interventions treatment Not Available unknown_status NCT02282267
Blood Detection of EGFR Mutation For Iressa Treatment treatment Not Available unknown_status NCT05400304
Radiomics Combined With Frozen Section Prediction Model for Spread Through Air Space in Lung Adenocarcinoma No drug interventions Not Available Not Available unknown_status NCT01578668
Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases treatment 2 completed NCT03391869
Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer treatment 3 recruiting NCT06031246
Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018) No drug interventions treatment 3 recruiting NCT06031181
Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019) No drug interventions treatment 3 recruiting NCT03544814
EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression treatment 2 completed NCT05925764
Whole Slide Image for Predicting the Novel Grading System of Resected Lung Adenocarcinoma No drug interventions Not Available Not Available recruiting NCT05279521
The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer. No drug interventions supportive_care Not Available not_yet_recruiting NCT02738684
A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test No drug interventions Not Available Not Available unknown_status